ProAmatine (midodrine)

Roberts Pharmaceutical

Approval Status
Approved September 1996

Treatment for

Cardiovascular / Cardiology

ProAmatine has been approved for the treatment of hypotension.

Hypotension is a low blood pressure condition characterized by a sudden drop in blood pressure upon assuming an upright posture. The condition is often accompanied by dizziness, lightheadedness, and fainting, which in older patients often leads to traumatic injury associated with falls.

ProAmatine (midodrine) Drug Information

The ProAmatine (midodrine) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top